Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
This product is currently not marketed in the UK. In the absence of a submission from the holder of the marketing authorisation, ketorolac/phenylephrine (Omidria®) cannot be endorsed for use within NHS Wales for the maintenance of intraoperative mydriasis, prevention of intraoperative miosis and reduction of acute postoperative ocular pain in intraocular lens replacement surgery. |
||
|
||
Medicine details |
||
| Medicine name | ketorolac / phenylephrine (Omidria®) | |
| Formulation | 12.37mg/ml/4.24mg/ml intraocular | |
| Reference number | 1194 | |
| Indication | Maintenance of intraoperative mydriasis, prevention of intraoperative miosis and reduction of acute postoperative ocular pain in intraocular lens replacement surgery |
|
| Company | Omeros Corp | |
| BNF chapter | Eye | |
| Assessment type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 26/07/2016 | |